Medicaid

Medicaid 56 % 55 %

Medicaid 56 % 55 %

Medicaid (1) $ 566,819 39.6 % $ 485,848 39.8 %

Medicaid (1) $ 543,450 39.3 % $ 453,840 38.9 %

Medicaid (1)(2) $ 2,002,007 39.8 % $ 1,682,344 39.7 % $ 1,459,449 39.4 %

Medicaid (1) $ 515,157 39.9 % $ 425,642 39.6 %

Medicaid 561,050 39.3 % 524,578 40.1 %

Medicaid 568,026 40.0 % 515,004 40.3 %

A substantial portion of our revenue is generated from payments from third-party payors, including Medicare and Medicaid, which represent our largest sources of revenue and accounted for 33.7% and 40.5% of our routine revenue for the year ended December 31, 2025, respectively.

Revenue from the Medicaid program amounted to 41.1% and 40.0% of the Company’s condensed consolidated net patient and resident revenue for the three months ended September 30, 2025 and 2024, respectively, and 40.5% and 39.8% of the Company’s condensed consolidated net patient and resident revenue for the nine months ended September 30, 2025 and 2024, respectively.

Revenue from the Medicaid program amounted to 40.1% and 40.0% of the Company’s condensed consolidated net patient and resident revenue for the three months ended June 30, 2025 and 2024, respectively, and 40.2% and 39.7% of the Company’s condensed consolidated net patient and resident revenue for the six months ended June 30, 2025 and 2024, respectively.

Revenue from the Medicaid program amounted to 40.3% and 39.4% of the Company’s condensed consolidated net patient and resident revenue for the three months ended March 31, 2025 and 2024, respectively.

Revenue from the Medicaid program amounted to 40.0% and 42.3% of the Company’s condensed combined/consolidated net patient and resident revenue for the three months ended September 30, 2024 and 2023, respectively, and 39.8% and 36.2% of the Company’s condensed combined/consolidated net patient and resident revenue for the nine months ended September 30, 2024 and 2023, respectively.

The following table presents revenue by payer type as a percentage of total revenue for the three and six-month periods ended July 4, 2026 and June 28, 2025, respectively: For the three-month periods ended For the six-month periods ended July 4, 2026 June 28, 2025 July 4, 2026 June 28, 2025 Medicaid MCO 59.4 % 58.6 % 59.4 % 58.6 % Medicaid 21.1 % 22.2 % 21.4 % 22.5 % Commercial 9.3 % 9.4 % 9.1 % 9.1 % Medicare 10.0 % 9.7 % 9.9 % 9.7 % Self-pay 0.2 % 0.1 % 0.2 % 0.1 % Total revenue 100.0 % 100.0 % 100.0 % 100.0 %

For the three-month periods ended April 4, 2026 March 29, 2025 Medicaid MCO 59.2 % 58.5 % Medicaid 21.8 % 22.8 % Commercial 8.9 % 8.8 % Medicare 9.9 % 9.8 % Self-pay 0.2 % 0.1 % Total revenue 100.0 % 100.0 %

The Company did not record any bad debt expense for the fiscal years ended January 3, 2026 or December 28, 2024.The following table presents revenue by payer type as a percentage of total revenue for the fiscal years ended January 3, 2026 and December 28, 2024: For the fiscal years ended January 3, 2026 December 28, 2024 Medicaid MCO 58.7 % 56.4 % Medicaid 22.8 % 23.5 % Commercial 8.5 % 9.6 % Medicare 9.9 % 10.4 % Self-pay 0.1 % 0.1 % Total revenue 100.0 % 100.0 %

The Company did not record any bad debt expense for the three and nine-month periods ended September 27, 2025 or September 28, 2024, respectively.The following table presents revenue by payer type as a percentage of total revenue for the three and nine-month periods ended September 27, 2025 and September 28, 2024, respectively: For the three-month periods ended For the nine-month periods ended September 27, 2025 September 28, 2024 September 27, 2025 September 28, 2024 Medicaid MCO 59.4 % 56.7 % 58.8 % 56.3 % Medicaid 23.3 % 25.0 % 22.8 % 23.4 % Commercial 7.4 % 7.9 % 8.5 % 9.7 % Medicare 9.7 % 10.3 % 9.7 % 10.5 % Self-pay 0.2 % 0.1 % 0.2 % 0.1 % Total revenue 100.0 % 100.0 % 100.0 % 100.0 %

The Company records revenue from Medicare, Medicaid, and managed care programs as services are performed at their expected net realizable amounts under these programs.

The Company records revenue from Medicare, Medicaid, and managed care programs as services are performed at their expected net realizable amounts under these programs.

Because of this diversified portfolio, our blended payor mix was 48.4% Medicare, 13.1% Medicaid, 15.0% managed care and 23.5% private pay and other payment sources for the year ended December 31, 2025.

The Company records revenue from Medicare, Medicaid, and managed care programs as services are performed at their expected net realizable amounts under these programs.

We derive revenue from a diversified blend of payors including Medicare and Medicaid programs, private pay patients and residents, and managed care payors.